New Measles vaccine on the horizon
This new vaccine cannot be co-administered with other childhood vaccines.
Sister Rianie Grové from Randgate pharmacy said a new measles (Measbio) vaccine will be replacing the current Rouvax vaccine in November.
The Department of Health said there will be a change in the route of administration since Sanofi Pasteur, the current supplier of the Measles vaccine has ceased the production of their Measles vaccine, Rouvax, and supplies of this will be running out in December.
Biovac Institute has registered a new Measles vaccine (Measbio) with MCC in South Africa which will be distributed to healthcare facilities from November.
This newly registered Measles vaccine can only be administered under the skin and cannot be co-administered with other childhood vaccines.
The needles for this vaccine are expected to be available from December. All facilities are urged to start administering Measbio from 1 December and parents should insure that their child receives the Measbio vaccine.
The new EPI Schedule as of 1 December is available on the website www.amayeza-info.co.za
Want to receive news alerts via WhatsApp? Send us an SMS/ WhatsApp message with your name and cellphone number to 079 413 8726.
Familiarise yourself with our WhatsApp service disclaimer.
Do you perhaps have more information pertaining to this story? Email us at randfonteinherald@caxton.co.za (remember to include your contact details) or phone us on 011 693 3671.
For free daily local news on the West Rand, also visit our sister newspaper websites Roodepoort Record, Krugersdorp News and Get It Joburg West Magazine
Remember to visit our Facebook, Twitter and Instagram pages to let your voice be heard!
